Skip to main content
SpringerLink
Log in

Neuropeptides vasopressin (AVP), oxytocin (OXT) and corticotropin-releasing hormone (CRH) in the human hypothalamus: activity changes in aging, Alzheimer’s disease and depressions

  • Invited Lecture
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Buijs R.M.: Vasopressin and oxytocin localization and putative functions in the brain. In: Pickard J.D., Cohadon F. Lobo Antunes J. (Eds.), Neuroendocrinological aspects of neurosurgery (Acta Neurochirurgica Suppl 47). Springer Verlag, Vienna/New York, 1990, pp. 86–99.

    Chapter  Google Scholar 

  2. Swaab D.F., Purba J., Hofman M.A.: Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J. Clin. Endocrinol. Metab. 80: 573–579, 1995.

    CAS  PubMed  Google Scholar 

  3. Tilders F.J.H., Schmidt E.D., De Goeij D.C.E.: Phenotypic plasticity of CRF neurons during stress. Ann. N.Y. Acad. Sci. 697: 39–52, 1993.

    Article  CAS  PubMed  Google Scholar 

  4. Goudsmit E., Hofman M.A., Fliers E., Swaab D.F.: The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer’s disease. Neurobiol. Aging 11: 529–536, 1990.

    Article  CAS  PubMed  Google Scholar 

  5. Lucassen P.J., Ravid R., Gonatas N.K., Swaab D.F.: Activation of the human supraoptic and paraventricular nucleus neurons with age and in Alzheimer’s disease as judged from an increase in size of the Golgi Apparatus. Brain Res. 632: 105–113, 1993.

    Article  CAS  PubMed  Google Scholar 

  6. Swaab D.F., Jongkind J.F.: Influence of gonadotropic hormones on the hypothalamic neurosecretory activity in the rat. Neuroendocrinology 8: 36–47, 1971.

    Article  CAS  PubMed  Google Scholar 

  7. Lucassen P.J., Salehi A., Pool C.W., Gonatas N.K., Swaab D.F.: Activation of vasopressin neurons in aging and in Alzobserved heimer’s disease. J. Neuroendocrinol. 6: 673–679, 1994.

    Article  CAS  PubMed  Google Scholar 

  8. Salehi A., Lucassen P.J., Pool C.W., Gonatas N.K., Ravid R., Swaab D.F.: Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer’s disease as determined by the size of the Golgi Apparatus. Neuroscience 4: 871–882, 1994

    Article  Google Scholar 

  9. Swaab D.F., Hofman M.A., Lucassen P.J., Salehi A., Uylings H.B.M.: Neuronal atrophy, not cell death, is the main hallmark of Alzheimer’s disease. Neurobiol. Aging 15: 369–371, 1994

    Article  CAS  PubMed  Google Scholar 

  10. Swaab D.F., Lucassen P.J., Van de Nes J.A.P., Ravid R., Salehi A.: Inactivity of neurons is a major hallmark of Alzheimer’s disease. Proceedings Fondation IPSEN; Conference sur Connexions, Cognition et Maladie d’Alzheimer, Paris, May 1996, 1997 (in press).

    Google Scholar 

  11. Lucassen P.J., Goudsmit E., Mengod G., Palacios J.M., Raadsheer F.C., Guldenaar S.E.F., Swaab D.F.: In situ hybridization for vasopressin mRNA in the human supraoptic and paraventricular nucleus; quantitative aspects of formalinfixed, paraffin embedded tissue sections as compared to cryostat sections. J. Neurosci. Meth. 57: 221–230, 1995 (+ corrigendum in J. Neurosci. Meth. 64: 133, 1996).

    Article  CAS  Google Scholar 

  12. Lucassen P.J., Van Heerikhuize J.J., Guldenaar S.E.F., Pool C.W., Hofman M.A., Swaab D.F.: Unchanged amounts of vasopressin mRNA in the supraoptic and paraventricular nucleus during aging and in Alzheimer’s disease. J. Neuroendocrinol. 9; 1997, (in press).

  13. Kingsbury A.E., Foster O.J.F., Nisbet A.P., Cairns N., Bray L., Eve D.J., Lees A.J., Marsden C.D.: Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Mol. Brain Res. 28: 311–318, 1995.

    Article  CAS  PubMed  Google Scholar 

  14. De Goey D.C.E., Kvetnansky R., Whitnall M.H., Jezova D., Berkenbosch F., Tilders F.J.H.: Repeated stress-induced activation of corticotropin-releasing factor enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats. Neuroendocrinology 53:150–159, 1991.

    Article  Google Scholar 

  15. Raadsheer F.C., Sluiter A.A., Ravid R., Tilders F.J.H., Swaab D.F.: Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus: age-dependent colocalization with vasopressin. Brain Res. 615:50–62, 1993

    Article  CAS  PubMed  Google Scholar 

  16. Raadsheer F.C., Hoogendijk W.J., Stam F.C., Tilders F.J.H., Swaab D.F.: Increased numbers of corticotropin-rleasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60:436–444, 1994

    Article  CAS  PubMed  Google Scholar 

  17. Raadsheer F.C., Tilders F.J.H., Swaab D.F.: Similar age-related increases of vasopressin colocalization in paraventricular corticotropin-releasing hormone neurons in controls and Alzheimer patients. J. Neuroendocrinol. 6: 131–133, 1994

    Article  CAS  PubMed  Google Scholar 

  18. Purba J., Hoogendijk W.J.G., Hofman M.A., Swaab D.F.: Increased number of vasopressin- and oxytocin-expressing neurons on the paraventricular nucleus of the hypothalamus in depression. Arch. Gen. Psych. 53: 137–143, 1996.

    Article  CAS  Google Scholar 

  19. Raadsheer F.C., Van Heerikhuize J.J., Lucassen P.J., Tilders F.J.H., Swaab D.F.: Increased corticotropin-releasing hormone (CRH) mRNA in the paraventricular nucleus of patients with Alzheimer’s disease and depression. Am. J. Psychiatry 152: 1372–1376, 1995.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Medical Pharmacology, Leiden Amsterdam Centre for Drug Research, Leiden University, P.O. Box 9503, 2300 RA, Leiden, The Netherlands

    P. J. Lucassen M.D.

  2. Graduate School Neurosciences, Netherlands Institute for Brain Research, Amsterdam, The Netherlands

    P. J. Lucassen M.D., A. Salehi & D. F. Swaab

  3. Dept Pharmacology, Free University, Amsterdam, The Netherlands

    F. J. H. Tilders

Authors
  1. P. J. Lucassen M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. J. H. Tilders
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Salehi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. F. Swaab
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lucassen, P.J., Tilders, F.J.H., Salehi, A. et al. Neuropeptides vasopressin (AVP), oxytocin (OXT) and corticotropin-releasing hormone (CRH) in the human hypothalamus: activity changes in aging, Alzheimer’s disease and depressions. Aging Clin Exp Res 9 (Suppl 4), 48–50 (1997). https://doi.org/10.1007/BF03339703

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03339703

Keywords

Search

Navigation